TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Toolkit to Improve Cardiovascular Disease Screening and Treatment for People With Type 2 Diabetes
Brief Summary: Diabetes is a common and serious chronic disease. However, there is a large gap between the level of care that people should receive (based on research and guidelines) and the level of care they actually receive. With the release of their 2008 Clinical Practice Guidelines, the Canadian Diabetes Association has a strategy to improve heart disease screening and treatment for people with diabetes. This study will evaluate whether the strategy works. The focus of the strategy was to give all family physicians in Canada a Toolkit in June 2009 to help them delivery better care for their diabetic patients. In Ontario, only half of doctors received this Toolkit. We will compare the quality of care received by diabetic patients whose doctors received this Toolkit versus those who doctors did not.


Options:
A: Arm Label: ATO-SR; Type: EXPERIMENTAL; Interventions: Behavioral: Automated Telephone Outreach with Speech Recognition | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: Other: Usual Care | Intervention Type: BEHAVIORAL; Name: Automated Telephone Outreach with Speech Recognition; Assigned to Arm(s): ATO-SR | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Intervention Type: BEHAVIORAL; Name: Nurse Case Management intervention; Assigned to Arm(s): N/A
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Toolkit | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Toolkit; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
D: Arm Label: care guide; Type: EXPERIMENTAL; Interventions: Behavioral: education and care guide | Arm Label: no care guide; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: education only | Intervention Type: BEHAVIORAL; Name: education and care guide; Assigned to Arm(s): care guide | Intervention Type: BEHAVIORAL; Name: education only; Assigned to Arm(s): no care guide

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba
Brief Summary: The primary purpose of the study is to investigate the efficacy and effectiveness of a community-based nurse managed telephone support line (Provincial Health Contact Center; PHCC) and Colorectal Cancer Information and Screening Website in supporting Primary Care Providers (PCP) from Winnipeg, Manitoba (Canada) in their efforts to improve colorectal cancer (CRC) screening Fecal Occult Blood Test (FOBT) compliance in average risk men and women 50-74 years of age. Secondary outcomes of the study involve documenting and investigating common patient questions and comments about CRC and the FOBT during their PHCC communication(s)/Website visits as well as procuring feedback from PCP and patients related to their experiences with the study protocol (PCP), FOBT (patients) and PHCC/website (patients).


Options:
A: Arm Label: FOBT by laboratory requisition or directly by PCP; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: FOBT by lab req. or directly from PCP + study magnet; Type: EXPERIMENTAL; Interventions: Behavioral: Refrigerator Magnet | Intervention Type: BEHAVIORAL; Name: Refrigerator Magnet; Assigned to Arm(s): FOBT by lab req. or directly from PCP + study magnet
B: Intervention Type: DEVICE; Name: Decision Aid Statin Choice; Assigned to Arm(s): N/A
C: Arm Label: Statin Choice Decision Aid; Type: ACTIVE_COMPARATOR; Interventions: Other: Statin Choice Decision Aid, Other: Usual care for antihyperglycemic medication | Arm Label: Diabetes Medication Choice Decision Aid; Type: ACTIVE_COMPARATOR; Interventions: Other: Diabetes Medication Choice Decision Aid, Other: Usual care for lipid therapy medication | Intervention Type: OTHER; Name: Diabetes Medication Choice Decision Aid; Assigned to Arm(s): Diabetes Medication Choice Decision Aid | Intervention Type: OTHER; Name: Statin Choice Decision Aid; Assigned to Arm(s): Statin Choice Decision Aid | Intervention Type: OTHER; Name: Usual care for lipid therapy medication; Assigned to Arm(s): Diabetes Medication Choice Decision Aid | Intervention Type: OTHER; Name: Usual care for antihyperglycemic medication; Assigned to Arm(s): Statin Choice Decision Aid
D: Arm Label: Vascular Access Patient Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: Vascular Access Decision Aid | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Vascular Access Decision Aid; Assigned to Arm(s): Vascular Access Patient Decision Aid

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase II, Parallel-group, Placebo Controlled, Double-blind, Randomised, Multicenter Study to Investigate the Efficacy of Two Dosages of Propionyl-L-Carnitine Colon Release Tablets in Patients Affected by Ulcerative Colitis Under Oral Stable Treatment
Brief Summary: The purpose of this study is to determine whether Propionyl-L-carnitine administration may ameliorate the illness in patients affected by mild to moderate ulcerative colitis already in treatment with one of the standard treatments (corticosteroids excluded).


Options:
A: Arm Label: PLC Colon release tablet 1 g; Type: EXPERIMENTAL; Interventions: Drug: Propionyl-L-Carnitine, Drug: Placebo | Arm Label: PLC colon release tablet 2 g; Type: EXPERIMENTAL; Interventions: Drug: Propionyl-L-Carnitine, Drug: Placebo | Arm Label: Placebo PLC colon release tablet 2 g; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Propionyl-L-Carnitine; Assigned to Arm(s): PLC Colon release tablet 1 g | Intervention Type: DRUG; Name: Propionyl-L-Carnitine; Assigned to Arm(s): PLC colon release tablet 2 g | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): PLC Colon release tablet 1 g, PLC colon release tablet 2 g, Placebo PLC colon release tablet 2 g
B: Arm Label: 30 children with UC; Type: N/A; Interventions: N/A
C: Intervention Type: DRUG; Name: mesalazine; Assigned to Arm(s): N/A
D: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: sterile saline for injection | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: MDX-1100 | Intervention Type: BIOLOGICAL; Name: sterile saline for injection; Assigned to Arm(s): 2 | Intervention Type: BIOLOGICAL; Name: MDX-1100; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to determine whether a High Intensity exercise intervention can elicit cardiovascular disease protection in adolescents.


Options:
A: Arm Label: Brief Motivational Counseling (BMC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Motivational Counseling (BMC) | Arm Label: Brief Motivational Counseling Plus Phone Calls (BMC+Phone); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Motivational Counseling (BMC), Behavioral: Brief Motivational Counseling Plus Phone Calls (BMC + Phone) | Arm Label: Brief Motivational Counseling Plus Home Visits (BMC+Home); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Motivational Counseling (BMC), Behavioral: Brief Motivational Counseling Plus Home Visits (BMC + Home) | Intervention Type: BEHAVIORAL; Name: Brief Motivational Counseling (BMC); Assigned to Arm(s): Brief Motivational Counseling (BMC), Brief Motivational Counseling Plus Home Visits (BMC+Home), Brief Motivational Counseling Plus Phone Calls (BMC+Phone) | Intervention Type: BEHAVIORAL; Name: Brief Motivational Counseling Plus Phone Calls (BMC + Phone); Assigned to Arm(s): Brief Motivational Counseling Plus Phone Calls (BMC+Phone) | Intervention Type: BEHAVIORAL; Name: Brief Motivational Counseling Plus Home Visits (BMC + Home); Assigned to Arm(s): Brief Motivational Counseling Plus Home Visits (BMC+Home)
B: Arm Label: High Intensity Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: High Intensity Exercise | Intervention Type: BEHAVIORAL; Name: High Intensity Exercise; Assigned to Arm(s): High Intensity Exercise
C: Arm Label: New Moves Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: New Moves | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: New Moves; Assigned to Arm(s): New Moves Intervention Group
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Advice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Recurrence of All Inner-city Strokes Through Education
Brief Summary: The purpose of this study is to evaluate if a peer-led stroke recurrence prevention intervention, versus usual care, will help reduce risk factors for recurrent strokes among adults in Harlem.


Options:
A: Arm Label: Arm 1 Secondary Risk Factor Management; Type: EXPERIMENTAL; Interventions: Behavioral: Physician stroke guideline adherence, Behavioral: Stroke Self Management | Arm Label: Attention Control Group; Type: PLACEBO_COMPARATOR; Interventions: Other: Attention Control Group | Intervention Type: BEHAVIORAL; Name: Physician stroke guideline adherence; Assigned to Arm(s): Arm 1 Secondary Risk Factor Management | Intervention Type: BEHAVIORAL; Name: Stroke Self Management; Assigned to Arm(s): Arm 1 Secondary Risk Factor Management | Intervention Type: OTHER; Name: Attention Control Group; Assigned to Arm(s): Attention Control Group
B: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Instruction in physical training program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Instruction in physical training program; Assigned to Arm(s): Intervention arm
C: Arm Label: Peer-Led Stroke Recurrence Prevention Education; Type: EXPERIMENTAL; Interventions: Behavioral: Prevent Return of Stroke | Arm Label: Usual Care (Delayed Intervention); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Prevent Return of Stroke | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Peer-Led Stroke Recurrence Prevention Education | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Usual Care (Delayed Intervention)
D: Arm Label: Standard care (SC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Arm Label: Interventional care (IC); Type: EXPERIMENTAL; Interventions: Behavioral: CAPSYS | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care (SC) | Intervention Type: BEHAVIORAL; Name: CAPSYS; Assigned to Arm(s): Interventional care (IC)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Recurrence of All Inner-city Strokes Through Education
Brief Summary: The purpose of this study is to evaluate if a peer-led stroke recurrence prevention intervention, versus usual care, will help reduce risk factors for recurrent strokes among adults in Harlem.


Options:
A: Arm Label: 1: Care management; Type: EXPERIMENTAL; Interventions: Behavioral: Care Management | Arm Label: 2: Written Materials; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written Materials | Intervention Type: BEHAVIORAL; Name: Care Management; Assigned to Arm(s): 1: Care management | Intervention Type: BEHAVIORAL; Name: Written Materials; Assigned to Arm(s): 2: Written Materials
B: Arm Label: Peer-Led Stroke Recurrence Prevention Education; Type: EXPERIMENTAL; Interventions: Behavioral: Prevent Return of Stroke | Arm Label: Usual Care (Delayed Intervention); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Prevent Return of Stroke | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Peer-Led Stroke Recurrence Prevention Education | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Usual Care (Delayed Intervention)
C: Arm Label: SystemCHANGE Group Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: SystemCHANGE Group Lifestyle counseling | Arm Label: Phone Lifestyle Counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Phone Lifestyle Counseling | Intervention Type: BEHAVIORAL; Name: SystemCHANGE Group Lifestyle counseling; Assigned to Arm(s): SystemCHANGE Group Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Phone Lifestyle Counseling; Assigned to Arm(s): Phone Lifestyle Counseling
D: Arm Label: Algorithm-based care; Type: OTHER; Interventions: Drug: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin | Arm Label: Health-promotion; Type: OTHER; Interventions: Behavioral: Health Promotion | Intervention Type: DRUG; Name: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin; Assigned to Arm(s): Algorithm-based care | Intervention Type: BEHAVIORAL; Name: Health Promotion; Assigned to Arm(s): Health-promotion

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Recurrence of All Inner-city Strokes Through Education
Brief Summary: The purpose of this study is to evaluate if a peer-led stroke recurrence prevention intervention, versus usual care, will help reduce risk factors for recurrent strokes among adults in Harlem.


Options:
A: Arm Label: 1: Care management; Type: EXPERIMENTAL; Interventions: Behavioral: Care Management | Arm Label: 2: Written Materials; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written Materials | Intervention Type: BEHAVIORAL; Name: Care Management; Assigned to Arm(s): 1: Care management | Intervention Type: BEHAVIORAL; Name: Written Materials; Assigned to Arm(s): 2: Written Materials
B: Arm Label: Peer-Led Stroke Recurrence Prevention Education; Type: EXPERIMENTAL; Interventions: Behavioral: Prevent Return of Stroke | Arm Label: Usual Care (Delayed Intervention); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Prevent Return of Stroke | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Peer-Led Stroke Recurrence Prevention Education | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Usual Care (Delayed Intervention)
C: Arm Label: PREVENT program; Type: EXPERIMENTAL; Interventions: Behavioral: PREVENT program | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: PREVENT program; Assigned to Arm(s): PREVENT program | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Arm Label: Regular care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Support program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient centered structured support program | Intervention Type: BEHAVIORAL; Name: Patient centered structured support program; Assigned to Arm(s): Support program

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Recurrence of All Inner-city Strokes Through Education
Brief Summary: The purpose of this study is to evaluate if a peer-led stroke recurrence prevention intervention, versus usual care, will help reduce risk factors for recurrent strokes among adults in Harlem.


Options:
A: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Communities That Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communities That Care | Intervention Type: BEHAVIORAL; Name: Communities That Care; Assigned to Arm(s): Communities That Care Intervention
B: Intervention Type: BEHAVIORAL; Name: lifestyle intervention; Assigned to Arm(s): N/A
C: Arm Label: Peer-Led Stroke Recurrence Prevention Education; Type: EXPERIMENTAL; Interventions: Behavioral: Prevent Return of Stroke | Arm Label: Usual Care (Delayed Intervention); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Prevent Return of Stroke | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Peer-Led Stroke Recurrence Prevention Education | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Usual Care (Delayed Intervention)
D: Arm Label: Passive Arm #1; Type: EXPERIMENTAL; Interventions: Behavioral: Active Arm #1, #2, Passive Arm #1, #2 | Arm Label: Passive Arm #2; Type: EXPERIMENTAL; Interventions: Behavioral: Active Arm #1, #2, Passive Arm #1, #2 | Arm Label: Active Arm #1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Arm #1, #2, Passive Arm #1, #2 | Arm Label: Active Arm #2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Arm #1, #2, Passive Arm #1, #2 | Intervention Type: BEHAVIORAL; Name: Active Arm #1, #2, Passive Arm #1, #2; Assigned to Arm(s): Active Arm #1, Active Arm #2, Passive Arm #1, Passive Arm #2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: B-LONG: An Open-Label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant, Long-acting Coagulation Factor IX Fc Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding in Previously Treated Subjects With Severe Hemophilia B
Brief Summary: The primary objectives of the study were: to evaluate the safety and tolerability of rFIXFc; to evaluate the efficacy of rFIXFc in all treatment arms; to evaluate the effectiveness of prophylaxis over on-demand (episodic) therapy by comparing the annualized number of bleeding episodes between participants receiving rFIXFc on each prevention (prophylaxis) regimen and participants receiving rFIXFc on an episodic regimen. The secondary objectives of the study were: to evaluate and assess the pharmacokinetic (PK) parameter estimates of rFIXFc and rFIX (BeneFIX®) at baseline in the Sequential PK subgroup as well as rFIXFc at Week 26 (±1 week); to evaluate participants' response to treatment; to evaluate rFIXFc consumption.


Options:
A: Arm Label: Prophylaxis; Type: EXPERIMENTAL; Interventions: Biological: rIX-FP | Arm Label: On-demand; Type: EXPERIMENTAL; Interventions: Biological: rIX-FP | Intervention Type: BIOLOGICAL; Name: rIX-FP; Assigned to Arm(s): On-demand, Prophylaxis
B: N/A
C: Arm Label: Prophylaxis; Type: EXPERIMENTAL; Interventions: Biological: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, Biological: PEGylated Recombinant Factor VIII | Arm Label: On-demand; Type: EXPERIMENTAL; Interventions: Biological: PEGylated Recombinant Factor VIII | Intervention Type: BIOLOGICAL; Name: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method; Assigned to Arm(s): Prophylaxis | Intervention Type: BIOLOGICAL; Name: PEGylated Recombinant Factor VIII; Assigned to Arm(s): Prophylaxis | Intervention Type: BIOLOGICAL; Name: PEGylated Recombinant Factor VIII; Assigned to Arm(s): Prophylaxis | Intervention Type: BIOLOGICAL; Name: PEGylated Recombinant Factor VIII; Assigned to Arm(s): On-demand
D: Arm Label: Fixed Weekly Interval; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc), Drug: rFIX | Arm Label: Individualized Interval; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc) | Arm Label: On Demand; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc) | Arm Label: Surgery; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc) | Intervention Type: DRUG; Name: Factor IX (rFIXFc); Assigned to Arm(s): Fixed Weekly Interval, Individualized Interval, On Demand, Surgery | Intervention Type: DRUG; Name: rFIX; Assigned to Arm(s): Fixed Weekly Interval

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: B-LONG: An Open-Label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant, Long-acting Coagulation Factor IX Fc Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding in Previously Treated Subjects With Severe Hemophilia B
Brief Summary: The primary objectives of the study were: to evaluate the safety and tolerability of rFIXFc; to evaluate the efficacy of rFIXFc in all treatment arms; to evaluate the effectiveness of prophylaxis over on-demand (episodic) therapy by comparing the annualized number of bleeding episodes between participants receiving rFIXFc on each prevention (prophylaxis) regimen and participants receiving rFIXFc on an episodic regimen. The secondary objectives of the study were: to evaluate and assess the pharmacokinetic (PK) parameter estimates of rFIXFc and rFIX (BeneFIX®) at baseline in the Sequential PK subgroup as well as rFIXFc at Week 26 (±1 week); to evaluate participants' response to treatment; to evaluate rFIXFc consumption.


Options:
A: Arm Label: Prophylaxis; Type: EXPERIMENTAL; Interventions: Biological: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, Biological: PEGylated Recombinant Factor VIII | Arm Label: On-demand; Type: EXPERIMENTAL; Interventions: Biological: PEGylated Recombinant Factor VIII | Intervention Type: BIOLOGICAL; Name: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method; Assigned to Arm(s): Prophylaxis | Intervention Type: BIOLOGICAL; Name: PEGylated Recombinant Factor VIII; Assigned to Arm(s): Prophylaxis | Intervention Type: BIOLOGICAL; Name: PEGylated Recombinant Factor VIII; Assigned to Arm(s): Prophylaxis | Intervention Type: BIOLOGICAL; Name: PEGylated Recombinant Factor VIII; Assigned to Arm(s): On-demand
B: Arm Label: Fixed Weekly Interval; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc), Drug: rFIX | Arm Label: Individualized Interval; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc) | Arm Label: On Demand; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc) | Arm Label: Surgery; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc) | Intervention Type: DRUG; Name: Factor IX (rFIXFc); Assigned to Arm(s): Fixed Weekly Interval, Individualized Interval, On Demand, Surgery | Intervention Type: DRUG; Name: rFIX; Assigned to Arm(s): Fixed Weekly Interval
C: Arm Label: Group 1; Type: OTHER; Interventions: Genetic: Gene Transfer, Drug: scAAV2/8-LP1-hFIXco | Intervention Type: GENETIC; Name: Gene Transfer; Assigned to Arm(s): Group 1 | Intervention Type: DRUG; Name: scAAV2/8-LP1-hFIXco; Assigned to Arm(s): Group 1
D: N/A

Answer: B